UBS Group AG - ALTAMIRA THERAPEUTICS LTD ownership

ALTAMIRA THERAPEUTICS LTD's ticker is and the CUSIP is G0360L100. A total of 19 filers reported holding ALTAMIRA THERAPEUTICS LTD in Q3 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ALTAMIRA THERAPEUTICS LTD
ValueSharesWeighting
Q3 2022$2,000
-84.6%
8,133
-68.8%
0.00%
Q2 2022$13,000
+225.0%
26,074
+648.0%
0.00%
Q1 2022$4,000
-69.2%
3,486
-52.6%
0.00%
Q4 2021$13,000
+62.5%
7,355
+87.5%
0.00%
Q3 2021$8,0003,9230.00%
Other shareholders
ALTAMIRA THERAPEUTICS LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Ikarian Capital, LLC 304,791$553,0000.08%
TWO SIGMA SECURITIES, LLC 10,497$19,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 30,753$56,0000.00%
JANE STREET GROUP, LLC 10,114$18,0000.00%
Stonebridge Capital Advisors LLC 100$00.00%
UBS Group AG 7,355$13,0000.00%
Cornerstone Advisory, LLC 5$00.00%
OSAIC HOLDINGS, INC. 310$1,0000.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
WELLS FARGO & COMPANY/MN 500$1,0000.00%
View complete list of ALTAMIRA THERAPEUTICS LTD shareholders